v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
REVENUES $ 3,015 $ 3,964
COST OF REVENUES 2,144 2,807
GROSS PROFIT 871 1,157
RESEARCH AND DEVELOPMENT EXPENSES 9,639 6,884
SALES AND MARKETING EXPENSES 2,327 1,218
GENERAL AND ADMINISTRATIVE EXPENSES 7,040 5,562
OPERATING LOSS (18,135) (12,507)
FINANCING INCOME, NET 1,100 740
NET LOSS $ (17,035) $ (11,767)
Net loss per share basic $ (1.07) $ (1.03)
Net loss per share diluted $ (1.07) $ (1.03)
Weighted average common shares basic 15,900 11,445
Weighted average common shares diluted 15,900 11,445